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Abstract
We performed a meta-analysis to synthesize evidence on the efficacy and safety of physical exercise as an add-on therapeutic 
intervention for quality of life (QoL), depressive symptoms and cognition across six chronic brain disorders: Alzheimer’s 
disease, Huntington’s disease, multiple sclerosis, Parkinson’s disease, schizophrenia and unipolar depression. 122 studies 
( = k) (n = 7231) were included. Exercise was superior to treatment as usual in improving QoL (k = 64, n = 4334, ES = 0.40, 
p < 0.0001), depressive symptoms (k = 60, n = 2909, ES = 0.78, p < 0.0001), the cognitive domains attention and working 
memory (k = 21, n = 1313, ES = 0.24, p < 0.009), executive functioning (k = 14, n = 977, ES = 0.15, p = 0.013), memory 
(k = 12, n = 994, ES = 0.12, p = 0.038) and psychomotor speed (k = 16, n = 896, ES = 0.23, p = 0.003). Meta-regression showed 
a dose–response effect for exercise time (min/week) on depressive symptoms (β = 0.007, p = 0.012). 69% of the studies that 
reported on safety, found no complications. Exercise is an efficacious and safe add-on therapeutic intervention showing a 
medium-sized effect on QoL and a large effect on mood in patients with chronic brain disorders, with a positive dose–response 
correlation. Exercise also improved several cognitive domains with small but significant effects.
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Introduction
Chronic brain disorders are associated with reduced qual-
ity of life (QoL) [1–4], high prevalence of low mood and 
depression, stress sensitivity and cognitive dysfunction [5, 
6]. These sequelae are interdependent, as depressive mood 
and cognitive impairment are two main factors influencing 
QoL [1, 2, 4-8], while cognition is negatively influenced by 
depression [9]. Moreover, these general sequelae are associ-
ated with various adverse consequences such as poor treat-
ment compliance, loss of independence and even mortality 
[10]. In treatment of brain disorders, current clinical prac-
tice tends to focus on improving disease-specific symptoms 
(e.g., tremor and rigidity in Parkinson’s disease, psychosis in 
schizophrenia). Notably, however, patients with brain disor-
ders regard QoL and depressive mood as more important for 
their health status than disease-specific physical and mental 
symptoms [11]. Therefore, improvement of these common 
features should become an important target in treatment of 
chronic brain disorders.
Exercise therapy may positively affect QoL, depression 
and cognition across disorders. A leading example is stroke, 
in which physical exercise has shown favorable effects in 
improving a wide range of symptoms, such that it has now 
been incorporated and recommended in guidelines as part 
of the standard treatment [12–16]. In contrast, research on 
the efficacy of physical exercise in treatment of other brain 
disorders is still in its infancy and therefore not part of the 
standard care. Although several studies have investigated 
the effect of physical exercise in different chronic brain dis-
orders such as Alzheimer’s disease (AD) [17, 18], multiple 
sclerosis (MS) [19–21], Parkinson’s disease (PD) [22, 23], 
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Schizophrenia (Sz) [24, 25] and unipolar depression (UD) 
[26–28], results and mainly recommendations for clinical 
practice have been highly diverse [29]. As a consequence, 
current evidence for efficacy of exercise therapy is still dis-
puted and exercise is not part of the regular care offer for 
patients with aforementioned disorders in most countries.
Of note, the above-mentioned chronic brain disorders 
share underlying pathophysiological mechanisms. As such, 
neuroinflammation [30–33], imbalance in same neurotrans-
mitter (e.g., dopamine in Sz and PD [34, 35], serotonin in 
Sz and UD [36]) and growth factors (e.g., brain-derived 
neurotrophic factor; BDNF) [37, 38], and disturbed con-
nectivity (e.g., in default-mode network) [39–42] have been 
implicated in the pathophysiology of many of these brain 
disorders. Furthermore, a recent genome-wide associa-
tion study (GWAS) showed high degree of genetic overlap 
among many psychiatric disorders stating that the different 
psychiatric disorders do not reflect independent diseases 
but rather represent different overlapping phenotypes of the 
same clinical spectra [43].
The aforementioned shows how disease-specific research 
has de-emphasized and limited our understanding of sub-
stantial commonalities that exist across disorders. Consid-
ering the overlap in pathophysiology and clinical picture 
across chronic brain disorders, commonalities across disor-
ders outweigh the differences indicating that transdiagnos-
tic and disease-specific treatments might be at least equally 
effective. Therefore, by targeting the common functional 
relationships across disorders with transdiagnostic treat-
ments, both disease-specific and common shared factors 
can be targeted during treatment. Physical exercise can be 
such a transdiagnostic treatment for chronic brain disorders.
The objective of this study is to quantitatively review the 
effect of additional physical exercise on QoL, depressive 
symptoms and cognition across the above-mentioned disor-
ders. In addition, we aim to estimate the safety of exercise 
in aforementioned groups. There are of course more chronic 
brain disorders in which exercise therapy may be effective, 
but for reasons of feasibility we restricted this review to six 
different brain disorders of various origins.
Method
Literature search
This meta-analysis was performed according to the Pre-
ferred Reporting for Systematic Reviews and Meta-anal-
ysis (PRISMA) Statement [44]. A systematic search was 
performed in Pubmed (Medline), Embase, PsychInfo and 
Cochrane Database of Systematic Reviews (independently 
by MD, MS, and EL), using combinations of the follow-
ing search terms: ‘Alzheimer’, ‘AD’, ‘Huntington’, ‘HD’, 
‘multiple sclerosis’, ‘MS’, ‘Parkinson’, ‘PD’, ‘PDD’, ‘schizo-
phrenia’, ‘psychosis’, ‘psychotic’, ‘depression’, ‘depressive’, 
‘mood’, ‘affective’, ‘exercise’, ‘physical’, ‘training’, ‘endur-
ance’, ‘aerobic’, ‘anaerobic’, ‘resistance’, ‘sport’ and ‘yoga’ 
(Online Resource 1), with no year or language limits. Addi-
tionally, the Web of Sciences databases and review articles 
were examined for cross-references. The search cutoff date 
was 15th of September 2018. When necessary, correspond-
ing authors were contacted to provide full text details of the 
study outcome measures.
Inclusion criteria
By consensus (between MD, MS, EL, and IS), the following 
studies were included:
1. Randomized controlled trials (RCTs) investigating the 
effect of any type of physical exercise as an add-on inter-
vention on QoL, depressive symptoms and/or cognition
2. Studies investigating whole-body, or upper- or lower-
body exercise (i.e., organ-specific exercise such as res-
piration muscle or pelvic muscle training were excluded)
3. Studies including patients with a diagnosis of AD, HD, 
MS (idiopathic) PD, Sz [24] and UD (according to a 
diagnostic interview) in both the intervention and con-
trol group (i.e., mixed study populations were excluded)
4. RCTs with a cross-over design providing data for the 
first study period
5. Studies investigating combined interventions when the 
control group received the same non-exercise compo-
nent of the intervention (e.g., exercise + medication ver-
sus medication only)
6. Studies investigating rehabilitation programs, provided 
that physical exercise constituted a main part of the pro-
gram
7. Studies reported sufficient information to compute com-
mon effect size (ES) statistics [i.e., mean and standard 
deviations (SDs), exact F, p, t, or z values] or corre-
sponding authors could provide these data upon request
8. If multiple publications were retrieved that described the 
same cohort, only the sample with largest overall sample 
size and/or original data was included
Exclusion criteria
1. Studies investigating same type of physical exercise in 
both the intervention and control group
2. Abstracts of studies (without full-text available) with 
insufficient information about the physical exercise 
intervention and/or outcome measures to calculate 
ES and untraceable corresponding information of the 
authors
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Outcome measures
The outcome measures included pre- and post-intervention 
assessments (i.e., measured directly after finishing the 
intervention and thus does not include follow-up meas-
urements) of QoL, depressive symptom severity and/or 
cognition. For measurements of depressive symptoms, 
observer-rated scales were preferred over self-rated ques-
tionnaires because of its higher validity [45]. The scales 
used to measure depression comprised Hamilton Depres-
sion Rating Scale (HDRS) [46], Beck Depression Inven-
tory (BDI) [47], Montgomery Asberg Depression Rating 
Scale (MADRS) [48], Geriatric Depression Scale (GDS) 
[49], Patient Health Questionnaire-9 (PHQ-9) [50], and 
Profile of Mood States (POMS) [51].
Based on the cognitive domains and/or cognitive tests 
investigated across studies and disorders, the following six 
cognitive domains were classified: attention and working 
memory (A&WM), executive functioning (EF), memory 
(M), psychomotor speed (PS), verbal fluency (VF) and 
global cognition (GC) (Online Resource 2). To combine 
studies across disorders, the most stringent control group 
per disorder [i.e., treatment as usual (TAU) allowing treat-
ments such as disease-specific medication, reading news-
papers, educational sessions but no active treatments such 
as occupational therapy] was used as a reference group.
Assessment of risk of bias
According to the Cochrane Handbook of Systematic 
Reviews of Interventions [52], risk of bias was assessed 
for all eligible studies regarding selection bias, detec-
tion bias, attrition bias and reporting bias. Attrition bias 
was divided into assessment of incomplete outcome data 
(i.e., drop-out and exclusions) and intention-to-treat (ITT) 
analysis as ITT is considered the least biased method to 
measure intervention effects in RCTs [52]. Performance 
bias was not assessed, as it is usually not possible to blind 
study participants to whether or not exercise intervention 
is performed.
Data analysis
All analyses were performed using Comprehensive Meta-
Analysis Version 2.0. Per outcome measure, the effect of 
additional exercise (versus control group) was quantified 
for each study using Hedges’ g based on change scores 
(end of treatment minus baseline). When these were not 
reported, pre- and post-treatment mean values and SDs, 
or exact F, p, t, or z values were used. For studies that 
did not report exact SDs, these were calculated using 
the 95% confidence intervals (SD = sqrt(N)  ×  [upper 
limit-lower limit]/[2  ×  1.96]) or standard error (SE) 
(SD = SE × sqrt(N)).
To achieve a single pair-wise comparison between exer-
cise and TAU, if a study investigated two or more types of 
exercise intervention, groups were combined for the main 
analysis [53] but studied separately in the moderator analysis 
(see further). The ES of the individual intervention groups 
were combined to calculate a composite ES by incorporating 
the ES and variance of each individual intervention while 
taking into account the correlation among the different inter-
ventions [54]. Likewise, when a study used more than one 
questionnaire to measure QoL or depressive symptoms, or 
multiple neuropsychological tests to measure a cognitive 
domain, a composite ES was calculated. As the correla-
tion among interventions or test measures was mostly not 
reported, a correlation of 0.5 was taken for all the computa-
tions to avoid under- and overestimation of the overall ES 
[54].
Studies were combined in meta-analysis to calculate a 
mean weighted ES for each outcome measure (see Online 
Resource 3 for formulas). A random-effects model was con-
sidered appropriate given the heterogeneity across studies 
and diagnoses. Moreover, a random-effects model allows 
generalization of the results on population level [55]. ES 
were interpreted according to Cohen [56], with an ES of 
0.2 indicating a small effect, 0.5 a medium and ≥ 0.8 a large 
effect. First, analyses were performed including all suitable 
studies per outcome measure. Subsequently, analyses were 
repeated by excluding outlier studies, defined as studies 
with standardized residual z scores of ES exceeding ± 1.96 
(p < 0.05, two-tailed; shown in Figs. 2, 3, 4), studies with 
small total sample sizes (n < 20) because of high risk of sam-
pling error in effect estimates [57] and studies with high 
risk of bias (i.e., considering the aim of the meta-analysis to 
study RCTs, studies classified as having high risk of bias on 
randomization and allocation concealment were excluded). 
ES with p < 0.05 were considered significant. Heterogene-
ity of results across studies was assessed by calculating the 
Q-statistic and I2-statistic. Q-Statistic tests the existence of 
heterogeneity and displays a Chi-square distribution with 
k−1 degrees of freedom (k = number of studies). Q values 
higher than the degrees of freedom indicate significant 
between-studies variability. I2 describes the percentage of 
total variation across studies due to heterogeneity rather than 
chance. I2 values of 25%, 50%, and 75% are considered as 
low, moderate, and high heterogeneity, respectively [58].
Potential publication bias was investigated by visual 
inspection of the funnel plots, with asymmetrical funnel 
plots indicating publication bias. When appropriate, the fun-
nel plot asymmetry was tested with Egger’s test (p < 0.05, 
two-tailed) [59]. Additionally, Rosenthal’s fail-safe num-
ber (NR) was calculated for significant ES, estimating the 
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number of unpublished studies with non-significant results 
needed to bring the observed result to non-significance [60].
Moderator analyses
Subgroup analyses were performed for ‘type of exercise’ 
classified as aerobic, resistance, or neuromotor exercise 
(e.g., yoga) according to the American College of Sports 
Medicine (ACSM) Guideline [61].
Since an insufficient number of studies examined the 
effect of flexibility exercise only, analysis was not feasible 
for this type of exercise.
Random effects meta-regression analyses were conducted 
to evaluate the effect of the following continuous moderator 
variables using the unrestricted maximum likelihood model:
– Exercise time (min/week)
– Total length of the intervention period (weeks)
– Age (overall mean age across study groups per study)
If a study reported a range for any of these variables, the 
mean value of the variable was calculated from the upper 
and lower bounds. To include each pair-wise comparison 
separately in these sensitivity analyses, for studies with mul-
tiple intervention groups but one shared control group, the 
total number of participants in the control group were evenly 
divided up among the comparisons [53].
Since a large number of the included studies did not pro-
vide sufficient information about the intensity and safety of 
the exercise intervention and most of the included studies 
(80%) investigated supervised exercise intervention, a sub- 
or meta-regression analysis was not possible to investigate 
the effect of these parameters. The intensity and safety of the 
exercise interventions were assessed qualitatively.
Results
A total of 400 articles investigating the effect of any type of 
exercise intervention for patients with chronic brain disor-
ders were retrieved from the literature search (AD: k = 40, 
HD: k = 6, MS: k = 137, PD: k = 124, Sz: k = 29, UD: k = 64), 
see Fig. 1.
A descriptive overview of these studies is provided in 
Online Resource 4. Of these, 163 studies fulfilled the inclu-
sion criteria and were eligible for meta-analysis [62–224]. 
Forty-one studies provided insufficient information to com-
pute common effect size. Therefore, a final total of 122 stud-
ies could be combined in meta-analysis. Risk of bias of all 
the eligible studies is shown in Online Resource 5 with a 
corresponding elaborative assessment of the studies included 
in the meta-analysis.
Quality of life
Sixty-four studies (n = 4334) examined the effect of exercise 
on QoL. Exercise showed a significant medium-size effect 
(ES = 0.40, 95% CI 0.27–0.52, p < 0.0001; Fig. 2, Table 1). 
Heterogeneity was high [Q(63) = 250.18, p < 0.0001; 
I2 = 75%], indicating that 75% of the dispersion seen in Fig. 2 
reflects difference in the true effect sizes while the remain-
ing 25% can be attributed to random sampling error. Five 
studies [68, 142, 186, 200, 217] were identified as outliers, 
six studies [68, 119, 173, 200, 208, 216] had small sample 
sizes (n < 20) and another four studies [135, 140, 165, 193] 
were classified as having high risk of bias. After exclusion, 
ES decreased, but remained significant (k = 51, n = 3895, 
ES = 0.31, 95% CI 0.19–0.43, p < 0.0001). Heterogeneity 
decreased, but remained moderate to high [Q(50) = 159.13, 
p < 0.0001; I2 = 69%]. Funnel plot and Egger’s test indicated 
potential publication bias before [t(62) = 5.00, p < 0.0001, 
NR = 1898], and after exclusion of the studies [t(49) = 3.39, 
p < 0.010, NR = 847] but with very high fail-safe numbers 
(Table 1). 
Within-disorder analysis showed a positive effect of exer-
cise on QoL in patients with MS, PD and Sz (Table 2).
Depressive symptoms
Sixty studies (n = 2909) showed a significant large-size 
effect of exercise on depressive symptoms (ES = 0.78, 95% 
CI 0.58–0.98, p < 0.0001; Fig. 3), with high heterogeneity 
[Q(59) = 367.90, p < 0.0001; I2 = 84%; Table 1]. Excluding 
eight outliers [75, 101, 104, 108, 112, 159, 220, 221], seven 
small studies (n < 20) [68, 82, 87, 95, 190, 207, 225] and two 
studies [99, 193] with high risk of bias decreased the overall 
ES to a medium effect (k = 43 n = 2430, ES = 0.47, 95% CI 
0.32–0.62, p < 0.0001). Heterogeneity reduced to moder-
ate to high [Q(42) = 130.55, p < 0.0001; I2 = 68%]. Funnel 
plot and Egger’s test indicated potential publication bias 
[t(58) = 6.10, p < 0.0001, NR = 3937], which remained after 
exclusion of the outliers [t(41) = 3.97, p < 0.001, NR = 1088; 
Table 1].
Within-disorder analysis showed a positive effect of 
exercise on depressive symptoms in AD, MS, Sz and UD 
(Table 2).
Cognition
Of the 120 studies, 36 studies (AD: k = 12, HD: k = 3, MS: 
k = 7, PD: k = 7, Sz: k = 3, UD: k = 4), examining 2125 
patients, evaluated cognitive functioning and were included.
Fig. 1  PRISMA flow chart of the literature search. AD Alzheimer’s 
disease, HD Huntington’s disease, MS multiple sclerosis, PD Parkin-
son’s disease, Sz schizophrenia, UD unipolar depression
◂
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Attention and working memory
Exercise showed a significant small effect on attention 
and working memory (k = 21, n = 1313, ES = 0.24, 95% 
CI 0.06–0.41, p = 0.009; Fig.  4) with moderate het-
erogeneity [Q(20) = 40.83, p = 0.004; I2 = 51%]. Eight 
(40%) out of 20 studies comprised AD, HD or PD. The 
funnel plot and Egger’s test indicated potential publica-
tion bias [t(19) = 2.14, p = 0.046, NR = 55] (Table 1). 
The ES remained significant after excluding one outlier 
study [219], four small studies (n < 20) [163, 181, 190, 
225] and one study [193] with high risk of bias (k = 14, 
n = 923, ES = 0.25, 95% CI 0.08–0.42, p = 0.004). 
Fig. 2  Meta-analysis of the effect of physical exercise on quality of 
life. Effect sizes (ES) per study and the overall ES are in Hedges’ g 
with corresponding p values and sample size of the intervention and 
control group. Standardized residual z scores of ES were used to 
detect outlier studies
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Heterogeneity turned low to moderate [Q(13) = 20.83, 
p = 0.076; I2 = 38%]. Egger’s test was non-significant 
(Table 1).
Executive functioning
Fourteen studies (n = 977) showed a significant small effect 
of exercise on executive functioning (ES = 0.15, 95% CI 
0.03–0.27, p = 0.013; Fig. 4). Five (35.7%) out of 14 stud-
ies investigated physical exercise in AD, HD or PD. Stud-
ies were homogenous [Q(13) = 12.30, p = 0.503; I2 = 0%]. 
Egger’s test was non-significant (Table 1). After excluding 
one outlier [63] and three small studies [68, 163, 190], ES 
remained significant (k = 10, n = 916, ES = 0.17, 95% CI 
0.04–0.29, p = 0.009). There were no studies with high risk 
of bias.
Memory
Twelve studies (n = 994) examined the effect of physical 
exercise on memory and showed a beneficial small effect 
of exercise (involving mainly aerobic exercise) (ES = 0.12, 
95% CI 0.07–0.24, p = 0.038; Fig. 4). Four (33.3%) out of 2 
studies comprised AD, HD or PD. Studies were homogenous 
[Q(11) = 10.74, p = 0.465; I2 =  0%]. Egger’s test was non-
significant (Table 1). After excluding one outlier study [128] 
and one small study [225], ES was non-significant (k = 9, 
n = 939, ES = 0.09, 95% CI − 0.03 to 0.21, p = 0.127), while 
studies remained homogenous (Table 1).
Psychomotor speed
Exercise showed a significant small effect on psychomo-
tor speed (k = 16, n = 896, ES = 0.23, 95% CI 0.08 to 0.38, 
p = 0.003; Fig. 4). Five (31.3%) out of 16 studies were based 
on AD, HD or PD. Heterogeneity among studies was low 
[Q(15) = 19.02, p = 0.213; I2 = 21%]. Funnel plot and Egg-
er’s test indicated potential publication bias [t(14) = 2.36, 
p = 0.035, NR = 42]. After excluding one outlier [65] and four 
small studies [162, 163, 190, 225], ES remained significant 
(k = 10, n = 786, ES = 0.14, 95% CI 0.005–0.27, p = 0.042). 
Studies showed complete homogeneity and Egger’s test was 
non-significant (Table 1).
Verbal fluency
Exercise showed no significant effect on verbal fluency 
(k = 6, n = 540, ES = 0.24, 95% CI − 0.07 to 0.55, p = 0.134; 
Fig. 4) and remained non-significant after excluding one out-
lier study [65] (k = 5, n = 510, ES = 0.06, 95% CI − 0.15 to 
0.27, p = 0.569). Four (66.7%) out of six studies comprised 
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Table 2  Results per disorder for all outcome measures




5 234/224 0.40 − 0.10 to 0.91 0.119 Q(4) = 23.51, 
p < 0.0001
83 t(3) = 1.30, 
p = 0.283
 Without outlier 4 227/217 0.22 − 0.24 to 0.68 0.345 Q(3) = 15.90, 
p = 0.001




3 35/32 0.31 − 0.25 to 0.88 0.280 Q(2) = 3.39, 
p = 0.184
41 t(1) = 5.05, 
p = 0.124





25 909/641 0.41 0.24 to 0.58 < 0.0001 Q(24) = 72.61, 
p < 0.0001
67 t(23) = 2.20, 
p = 0.038
380
 Without outlier 21 749/551 0.39 0.25 to 0.54 < 0.0001 Q(20) = 34.99, 
p = 0.020




19 887/852 0.31 0.08 to 0.54 0.009 Q(18) = 81.45, 
p < 0.0001
78 t(17) = 2.94, 
p = 0.009
59
 Without outlier 14 825/793 0.18 − 0.04 to 0.41 0.112 Q(13) = 52.43, 
p < 0.0001
75 t(12) = 2.05, 
p = 0.063
 Schizophrenia 5 130/88 0.89 0.22 to 1.55 0.009 Q(4) = 21.02, 
p < 0.0001
81 t(3) = 1.67, 
p = 0.194
 Without outlier 3 110/72 0.43 − 0.13 to 0.99 0.130 Q(2) = 6.35, 
p = 0.042




7 154/148 0.34 − 0.04 to 0.72 0.082 Q(6) = 10.08, 
p = 0.004





5 264/254 0.80 0.12 to 1.49 0.022 Q(4) = 48.15, 
p < 0.0001
92 t(3) = 3.46, 
p = 0.041
24
 Without outlier 3 237/227 0.05 − 0.16 to 0.24 0.653 Q(2) = 2.38, 
p = 0.305









14 327/249 0.45 0.12 to 0.79 0.007 Q(13) = 47.78, 
p < 0.0001
73 t(12) = 2.30, 
p = 0.040
69
 Without outlier 13 291/231 0.23 0.06 to 0.40 0.010 Q(12) = 9.61, 
p = 0.650





5 116/100 0.05 − 0.36 to 0.45 0.822 Q(4) = 7.91, 
p = 0.095
49 t(3) = 0.83, 
p = 0.469
 Without outlier 3 89/77 -0.04 − 0.63 to 0.55 0.895 Q(2) = 6.22, 
p = 0.045
68 t(1) = 0.20, 
p = 0.874
 Schizophrenia 2 46/21 0.73 0.20 to 1.26 0.007 Q(1) = 0.89, 
p = 0.347
0





32 858/626 1.08 0.78 to 1.38 < 0.0001 Q(31) = 210.96, 
p < 0.0001
85 t(30) = 4.83, 
p < 0.0001
2024
 Without outliers 23 736/523 0.88 0.62 to 1.14 < 0.0001 Q(22) = 101.96, 
p < 0.0001




Attention and working memory
 Alzheimer’s 
disease
3 44/43 0.28 − 0.13 to 0.69 0.185 Q(2) = 2.30, 
p = 0.317




5 117/95 0.23 − 0.04 to 0.49 0.089 Q(4) = 4.16, 
p = 0.384
4 t(3) = 0.67, 
p = 0.550
 Without outlier 4 112/90 0.24 − 0.07 to 0.56 0.134 Q(3) = 4.16, 
p = 0.245
28 t(2) = 1.16, 
p = 0.365
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Table 2  (continued)
Outcome measure Studies (N) Patients (IG/CG) Hedges’ g 95% CI P value Q statistic (df) I2 (%) Egger’s  testa NR
 Parkinson’s 
disease
5 89/82 0.50 0.20 to 0.80 0.001 Q(4) = 2.63, 
p = 0.622
0 t(3) = 0.05, 
p = 0.962
 Without outliers 2 57/54 0.41 − 0.12 to 0.94 0.129 Q(1) = 1.61, 
p = 0.205
38
 Schizophrenia 4 373/184 0.07 − 0.41 to 0.55 0.776 Q(3) = 14.57, 
p = 0.002
79 t(2) = 0.54, 
p = 0.642
 Without outlier 3 365/174 0.04 − 0.51 to 0.60 0.879 Q(2) = 14.32, 
p = 0.001




4 171/115 0.22 − 0.24 to 0.68 0.351 Q(3) = 8.72, 
p = 0.033
66 t(2) = 1.14, 
p = 0.373
 Without outlier 3 163/107 0.17 − 0.36 to 0.70 0.540 Q(2) = 7.79, 
p = 0.020





3 78/82 0.03 − 0.58 to 0.64 0.921 Q(2) = 5.21, 
p = 0.074
62 t(1) = 0.0005, 
p = 1.000





4 76/56 0.15 − 0.18 to 0.47 0.370 Q(3) = 2.00, 
p = 0.572
0 t(2) = 0.49, 
p  = 0.673
 Without outlier 3 71/51 0.21 − 0.13 to 0.56 0.223 Q(2) = 0.74, 
p = 0.692




2 24/16 0.28 − 0.25 to 0.80 0.306 Q(1) = 0.70, 
p = 0.402
0
 Without outlier 1 15/8 0.08 − 0.62 to 0.78 0.827











3 127/110 0.05 − 0.18 to 0.28 0.666 Q(2) = 0.75, 
p = 0.688




2 48/30 0.48 − 0.53 to 1.48 0.352 Q(1) = 4.64, 
p = 0.031
78
 Schizophrenia 3 271/135 0.13 − 0.07 to 0.33 0.201 Q(2) = 0.89, 
p = 0.641
0 t(1) = 1.01, 
p = 0.496





3 154/99 0.17 − 0.04 to 0.38 0.104 Q(2) = 0.77, 
p = 0.680
0 t(1) = 0.69, 
p = 0.615






3 127/113 0.49 − 0.32 to 1.29 0.237 Q(2) = 10.38, 
p = 0.006




6 133/113 0.24 − 0.008 to 
0.48
0.058 Q(5) = 3.22, 
p = 0.667
0 t(4) = 0.68, 
p = 0.533
 Without outliers 4 118/99 0.22 − 0.04 to 0.48 0.099 Q(3) = 2.63, 
p = 0.452
0 t(2) = 0.20, 
p = 0.858
 Schizophrenia 2 77/43 0.45 0.07 to 0.83 0.020 Q(1) = 0.02, 
p = 0.886
0
 Without outlier 1 69/33 0.44 0.02 to 0.85 0.040
 Unipolar depres-
sion
3 154/99 0.18 − 0.05 to 0.41 0.133 Q(2) = 1.84, 
p = 0.398
0 t(1) = 1.74, 
p = 0.332
 Without outlier 2 146/91 0.14 − 0.10 to 0.38 0.238 Q(1) = 0.48, 
p = 0.487
0
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to high [Q(5) = 14.36, p = 0.014; I2 = 65%; Table 1] but 
decreased after excluding the outlier (Table 1).
Global cognition
Fifteen studies (n = 725), all comprising AD, HD or PD, 
showed a trend of exercise in improving global cogni-
tion (ES = 0.30, 95% CI − 0.03 to 0.63, p = 0.076; Fig. 4). 
ES increased and showed significance (k = 10, n = 620, 
ES = 0.39, 95% CI 0.09–0.68, p = 0.010) after excluding two 
outliers [63, 74], three small studies [68, 119, 190] and one 
study [193] with high risk of bias. Heterogeneity was high 
[Q(14) = 60.79, p < 0.0001; I2 = 77%] but decreased after 
exclusion of the studies [Q(9) = 26.15, p = 0.002; I2 = 66%]. 
Egger’s test was non-significant (Table 1).
Separate analyses per disorder showed beneficial effects 
of exercise on A and WM in PD, PS in Sz and on GC in AD 
and PD (Table 2).
The study by Oertel Knöchel et al. [105] and Maci et al. 
[68] investigated physical exercise in combination with a 
cognitive intervention. Exclusion of these studies did not 
change results for any of the outcome measures.
Studies with ITT‑analysis
Additional analyses with studies with only low or unclear 
risk of bias on ITT analyses showed even larger effect of 
exercise on both QoL (ES = 0.56) and depressive symptoms 
(ES = 0.90), while effect on the cognitive domain psychomo-
tor speed remained small (ES = 0.24) but significant. Effect 
of physical exercise on all the other cognitive domains was 
no longer significant. See Online Resource 6 for a detailed 
overview of these results.
Moderator analysis
Subgroup analysis showed a significant medium effect of 
aerobic and neuromotor exercise and a medium-to-large 
effect of resistance exercise on QoL and depressive symp-
toms. Furthermore, a comprehensive program including all 
types of exercises according to ACSM was also effective 
in improving QoL. For cognition, aerobic and neuromotor 
exercises showed significant effects (Table 1).
Meta-regression analysis showed a small but positive 
dose–response effect for the amount of weekly exercise in 
min/week in reducing depressive symptoms (β = 0.007, 95% 
CI 0.002–0.013, p = 0.012; Online Resource 7–8), indicating 
that every 1-min increase in exercise intervention per week 
corresponds to an 0.007 unit increase is ES. No significant 
effect was found for the moderator total length of interven-
tion (range 1.4–104 weeks). Additional meta-regression 
results are shown in Online Resource 7.
Intensity
With regard to intensity of the exercise intervention as pos-
sible moderator, 50 of the analyzed studies (41.0%) did not 
report any information. Of the remaining 59.0%, 18 studies 
(25.0%) investigated neuromotor exercises and therefore 
possibly could not report any intensity level. 36 studies 
(50.0%) applied low-to-moderate intensity of exercise, while 
16 studies (22.2%) investigated moderate-to-high intensity 
Table 2  (continued)




4 188/178 0.27 − 0.20 to 0.74 0.264 Q(3) = 12.23, 
p = 0.007





10 299/287 0.21 − 0.21 to 0.63 0.332 Q(9) = 50.92, 
p < 0.0001
82 t(8) = 0.19, 
p = 0.853
 Without outliers 7 271/260 0.32 0.02 to 0.63 0.039 Q(6) = 16.63, 
p = 0.011









3 53/36 0.71 − 0.03 to 1.45 0.060 Q(2) = 5.51, 
p = 0.064
64 t(1) = 0.07, 
p = 0.957
 Without outliers 1 26/13 1.45 0.69 to 2.21 < 0.0001
Results in bold indicate significant effect size
CG control group, df degrees of freedom, IG intervention group, NR Rosenthal’s fail-safe number
a Egger’s test cannot be performed for k ≤ 2
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exercise. Two studies (2.8%) investigated low-to-high inten-
sity exercise (Online Resource 9).
Safety
Sixty-five studies (53.3%) reported on safety aspects of the 
exercise intervention (Online Resource 10). Forty-five of 
these studies (69.2%) found no physical injuries related 
to exercise. Eighteen studies (27.7%) found physical inju-
ries that were related to the exercise intervention. These 
consisted mainly of muscle/joint pain (17.5%), fall inci-
dents (11.4%, all with complete recovery) and ankle sprain 
(1.9%). In 83.3% of these studies (k = 15), physical injuries 
were short-lasting and/or had no consequences for par-
ticipation in and completion of the exercise intervention.
Fig. 3  Meta-analysis of the effect of physical exercise on depres-
sive symptoms. Effect sizes (ES) per study and the overall ES are in 
Hedges’ g with corresponding p values and sample size of the inter-
vention and control group. Standardized residual z scores of ES were 
used to detect outlier studies
 Journal of Neurology
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Fig. 4  Meta-analysis of the 
effect of physical exercise on 
the cognitive domains (from top 
to down) attention and working 
memory, executive function-
ing, memory, psychomotor 
speed, verbal fluency and global 
cognition. Effect sizes (ES) per 
study and the overall ES are in 
Hedges’ g with corresponding 
p values and sample size of the 
intervention and control group. 
Standardized residual z scores 
of ES were used to detect outlier 
studies
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Discussion
One hundred and twenty-two studies, including 7231 
patients, showed a significant medium-size effect 
(ES = 0.40) of exercise as an add-on therapeutic interven-
tion on QoL (k = 64, n = 4334), a large effect (ES = 0.78) 
on depressive symptoms (k = 60, n = 2909) and a small 
but significant effect (ES = 0.12–0.24) on improving func-
tion in several cognitive domains. The effects for QoL and 
depression were well powered. The included number of 
patients was lower for cognition (k = 36, n = 2125), which 
makes these results more sensitive for new findings. From 
the studies that reported on safety (k = 18), low incidences 
of complications related to the exercise interventions were 
found, which had no lasting consequences for participation 
in and completion of the exercise interventions.
Current clinical practice
In present clinical practice, the role of physical exercise 
as an add-on therapy in the management of QoL, depres-
sive symptoms and cognitive impairment in chronic brain 
disorders remains elusive [226–228]. Management guide-
lines sometimes suggest physical exercise in treatment of, 
e.g., physical health, motor symptoms, falls and fatigue in 
chronic brain disorders but lack in clarity over the effec-
tiveness of physical exercise on the studied symptoms 
[229–235].
Chronic brain disorders commonly affect well being 
and QoL. Therefore, improvement of QoL is a main care 
objective in these disorders. Depressed mood and cognitive 
inabilities are important contributors to reduce QoL. Cur-
rently, evidence for treatment designed specifically to target 
QoL is lacking. Most treatments for chronic brain disorders 
alleviate disease-specific symptoms, progression or relapse. 
In contrast, exercise therapy targets overall well-being, mood 
and cognition, independent of type of disease.
At present, physical exercise is not generally viewed as 
an effective intervention. For example, in a recent review, 
Kok et al. evaluated treatment of depression in older adults 
and stated that depressive symptoms can be effectively 
treated with antidepressants whereas physical exercise 
may not be a mainstream treatment modality, yet might be 
considered as a complementary therapy [236]. In contrast, 
Turner et al., showed that the efficacy of antidepressants is 
subject to selective publication of positive studies with a 
precipitous drop in ES to an overall ES of 0.32 when non-
published FDA approved drug trials of antidepressants 
were combined with published drug trials [237].
For dementia, there are still no disease-modifying 
agents available and treatment is limited to amelioration 
of symptoms [238]. The effects for cognition found in 
our meta-analysis are statistically small but significant 
and similar or larger than effects of cognitive therapy 
[239–244] or drug treatment [245–248], which makes 
these effects relevant for cognitive outcomes.
Heterogeneity and moderators
To our knowledge, this is the first meta-analysis to assess the 
effect of physical exercise interventions across chronic brain 
disorders. Since heterogeneity between studies is a valid rea-
son of concern in meta-analyses, our study shows that when 
we consider brain disorders to share underlying mechanisms, 
it is feasible to combine disorders and studies across disor-
ders in a joint analysis. We found lower heterogeneities in 
the joint analysis compared to within-disorder analysis. High 
heterogeneity across studies and disorders was accounted 
for using the random-effects model and excluding outlier 
studies, small studies and studies with high risk of bias. As 
a consequence, for QoL and depressive symptoms, both het-
erogeneity and ES decreased, but exercise still showed a 
significant medium effect. Moderator analyses, performed to 
assess potential sources of heterogeneity, showed moderate 
variability between studies that investigated aerobic exer-
cises whereas studies that evaluated the efficacy of resistance 
or neuromotor exercises on QoL and depressive symptoms 
showed higher ES and no heterogeneity. Largest effects were 
found for resistance exercise. Better performance of resist-
ance exercise on these outcomes might be mediated by an 
increase in peripheral blood levels of Insulin-growth-factor-1 
(IGF-1), which can cross the blood–brain barrier and has 
been shown to regulate the effects of exercise on depression, 
learning, angiogenesis and hippocampal neurogenesis [249, 
250]. As one study evaluated the role of resistance exercise 
only on cognition, this result should be interpreted with cau-
tion. Heterogeneity across studies assessing cognition was 
low or completely lacking for all but two cognitive domains 
(i.e., attention and working memory and global cognition) 
that showed significant results. For cognition, neuromotor 
exercise resulted in higher effects than aerobic exercise. 
Neuromotor exercises involve multifaceted exercises that 
target different brain systems involved in the regulation of 
attention, balance, coordination, mood, motor functioning 
and cognition, amongst others. Hence, neuromotor exercises 
are suggested to improve synchronization between different 
brain areas, which might explain their efficacy on a wide 
variety of clinical symptoms [251].
We found a positive dose–response effect for the weekly 
time spent on exercise in min/week in reducing depressive 
symptoms, indicating that the more time spent on exercise 
per week, the larger the reduction in depressive symptoms. 
However, no significant dose–response effect was found for 
the total length of the exercise intervention (i.e., the number 
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of weeks spend on exercise), suggesting that both short- 
and long-term exercise interventions might be beneficial 
in improving QoL, depressive symptoms, and cognition. 
Patient groups ranged in mean age from 15.4 to 84.0 years, 
but no significant effect of this moderator was found on the 
outcome measures indicating that the effect of exercise on 
the examined outcome measure is not age-dependent.
Regarding exercise intensity, most of the studies that pro-
vided information on the intensity of the studied exercise 
intervention, applied moderate exercise intensity. Addition-
ally, we found that risk of possible complications due to 
exercise is low, which should not be considered a limiting 
factor for exercise intervention.
While all aforementioned moderators were expected to 
be an explanatory factor for the high heterogeneity in QoL, 
depressive symptoms and the cognitive domain global cog-
nition, the role of exercise intensity and safety could not be 
assessed quantitatively. One other explanation for the high 
heterogeneity could be the different questionnaires used in 
the separate studies. For both QoL and depressive symp-
toms, 13 different rating scales were used. For global cogni-
tion, six different tests were used.
Implications for clinical practice
Currently, physical exercise is not a standard part of the 
treatment of the six chronic brain disorders included in 
this study. Based on our work, it is likely that patients with 
any of the investigated brain disorders could benefit from 
additional physical exercise therapy. As safety issues and 
age constraints do not seem to be a limiting factor, health-
care professionals could use the present findings to provide 
patients with a tailored intervention in terms of type of exer-
cise, exercise time and duration of intervention period. We 
showed a positive dose–effect interaction for exercise time, 
indicating that longer exercise programs are better for mood 
improvement. Most studies included in our meta-analysis 
assessed supervised exercise. Therefore, our results cannot 
be generalized to unsupervised exercise.
Implications for further research
Given the purpose and transdiagnostic character of the 
present study, we chose to compare exercise intervention 
only to TAU control condition. Evaluation of any differen-
tial effects of other components of the interventions such 
as adherence, setting (e.g., home-based vs. gym-based), 
monitoring of exercise sessions with instruments (e.g., heart 
rate meters), cost-effectiveness and comparison with other 
control groups (e.g., active control conditions) is required 
to provide detailed recommendations on physical exercise 
interventions for the clinical practice.
Strengths and limitations
The greatest strength of the present study is that it provides 
an up-to-date and extensive quantitative overview of the 
literature regarding the efficacy of different exercise inter-
ventions in patients with chronic brain disorders. Second, 
our findings are largely in accordance with previous (quan-
titative) reviews that synthesized evidence on the efficacy 
of physical exercise in the studied brain disorders [20, 22, 
24, 25, 28, 252]. However, in contrast to previous work, we 
performed both transdiagnostic and within-disorder analy-
ses and evaluated the effect of several moderators provid-
ing evidence that physical exercise can be considered as an 
effective add-on and transdiagnostic treatment.
This study has some limitations. First, several studies 
could not be included in the cognitive meta-analyses, so 
that the overall effect of exercise on cognition was based on 
fewer studies than the other meta-analyses, making these 
findings more susceptible to change over time (when more 
studies become available). Notably, a recent RCT of 4-month 
aerobic and resistance exercise of moderate to high inten-
sity added to usual care found that physical exercise did not 
slow cognitive decline in patients with mild-to-moderate 
dementia [18]. The authors measured global cognition with 
Alzheimer’s disease assessment scale-cognitive subscale 
(ADAS-cog) and found a small average difference with 
uncertain clinical relevance. This study did not fulfill the 
inclusion criteria of our study to be included in the quantita-
tive review. However, considering the fact that we included 
four RCTs [65, 68, 74, 224] with negative outcomes of exer-
cise on global cognition in AD (see Fig. 4) and did not find a 
significant overall effect of exercise on global cognition, we 
do not expect that adding this study would have changed our 
findings. Second, the analysis regarding the effect of physi-
cal exercise on depressive symptoms included studies with 
different disorders, and the included studies also differed in 
the severity of depression, ranging from mild depression 
to the presence of major depressive disorder. This might 
have biased the findings and resulted in a high effect size. 
However, both low and high effect sizes were found in mild 
and major depression, which suggests that physical exercise 
is effective for depressive symptoms in general, irrespec-
tive of the underlying severity. Third, publication bias is 
an important possible drawback in meta-analytical stud-
ies. Egger’s test showed potential publication bias for QoL 
and depressive symptoms. However, the fail-safe numbers 
of these tests were extremely large, increasing the valid-
ity of the results. Fourth, heterogeneity among studies was 
high, possibly due to combining studies with largely dif-
ferent interventions offered to different groups. However, 
heterogeneity values of the joint analysis were lower than 
the within-disorder heterogeneities (Tables 1, 2), indicating 
consistency in studies across disorders so that joint analysis 
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of disorders deemed sensible. Moreover, one of the main 
inter-study differing variables, age, did not affect the effi-
cacy of exercise on the outcome measures. Besides, Q- and 
I2-statistic cannot be used to estimate the magnitude of true 
dispersion [253]. Fifth, for all outcome measures, the risk of 
bias assessment indicated highest risk in terms of attrition. 
Incomplete outcome data and lack of ITT-analysis in studies 
could have biased the observed results. However, to account 
for possible attrition bias, we performed separate analyses 
on studies that performed ITT-analysis and thus had low risk 
of bias and studies with unclear risk of bias on ITT analysis 
(i.e., insufficient information to judge). These results showed 
even higher effects of exercise on QoL and depressive symp-
toms, while effects on cognition remained similar for the 
cognitive domain PS, but turned to non-significance for the 
cognitive domains A and WM, EF and M. The latter is likely 
due to the moderate to high heterogeneity among studies 
after inclusion of the study by [219]. Finally, we randomly 
selected six brain disorders of various etiology (e.g., neuro-
degenerative, neurodevelopmental, inflammatory) to dem-
onstrate the generalizability of efficacy of exercise. Since 
we did not find any RCTs evaluating the effect of physical 
exercise in bipolar disorder, we decided to only include uni-
polar depression in the present study. Other brain disorders, 
such as epilepsy, traumatic brain injury and migraine have 
been investigated as well, but given restriction in time and 
capacity (as well as wordcount), this paper was confined to 
the chronic brain disorders summed above.
Conclusion
Additional therapy with physical exercise in patients with 
chronic brain disorders seems safe and has a medium-sized 
effect on QoL and a large beneficial effect on depressive 
symptoms, with a positive dose–response correlation. The 
evidence for the efficacy on cognition is small, but clinically 
relevant. Therefore, to improve the health status of patients 
with chronic brain disorders, add-on exercise therapy should 
be considered as an essential part of the treatment.
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